Eargo 5 vs Lexie B3

The Eargo 5 is a premium-priced OTC hearing aid ($1,450) featuring an invisible-in-ear design with rechargeable batteries. In our lab testing, it earned a B grade with a SoundScore of 3.6/5, placing it in the top 52% of the OTC hearing aid category. This device demonstrates solid performance for speech understanding in quiet environments, scoring 3.5/5—0.75 points above the category average of 2.79/5. Own-voice comfort also measures above average at 2.8/5 (+0.29 vs category), though this remains mixed in absolute terms. Feedback handling is strong at 4.2/5, providing reliable stability during wear. However, the Eargo 5 shows notable limitations in other areas. Speech in noise performance is low at 1.4/5, slightly below the category average. Most significantly, music streaming scored 0.0/5, falling 1.92 points below the category average—this device does not support audio streaming functionality. The invisible-in-ear form factor appeals to users prioritizing discretion, and the closed sleeve coupling remains consistent between initial and tuned fits. Tuning provided modest improvement, moving from a normalized Initial Score of 3.5/5 to a Tuned Score of 3.7/5. Given its premium price point, consumers may want to compare against alternatives like the Sony CRE-C10 or Nuance Audio Glasses, which offer similar or better sound performance at lower price points. The Eargo 5 is best suited for users who prioritize cosmetic discretion and primarily need help with speech in quieter settings.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.